All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Hypothermia has been shown to provide distinct medical benefits to myocardial infarction, traumatic brain injury, stroke, cardiac arrest and other patients by limiting the size of the infarction and related tissue injury if initiated soon enough and if the level of cooling is significant enough. Both of these limitations—initiation of and depth of cooling—have made practical application of the technology quite challenging, particularly in an ambulance or other emergency settings in the field. Initiation of cooling, for example, is a major issue since most technologies require sophisticated machinery that would be difficult to place in ambulance, so the patient, at best, receives the hypothermic benefit some time after they reach the hospital. Of the technologies that can be initiated in the field, such as cooling blankets, cooling caps, etc., the depth of cooling is a major issue due to surface area limitations, complications (such as intense shivering response) and patient access issues (once the blanket is on, it may be difficult to access the patient).
In addition to externally applied cooling, hypothermia may be induced by cooling the interior of the subject's body, such as by accessing the vasculature or an internal cavity. See, e.g., U.S. Pat. No. 5,752,929; U.S. Pat. No. 5,709,654 and US 2007/0106247.
The present invention relates to patient hypothermia systems and methods. Embodiments of the invention provide apparatus, systems and methods for achieving therapeutic hypothermia using minimally invasive access of the peritoneal cavity or other body cavity. Such embodiments can use minimally invasive methods to deliver and circulate hypothermic solutions to the peritoneal or other body cavity to reduce body temperature to a selected level for treatment of a number of medical conditions where there is diminished perfusion to one or more locations in the body. Such conditions can include various cardiac conditions including myocardial infarction and cardiac arrest; cerebral conditions including stroke and head trauma; and various hemorrhagic events due to arterial dissection or rupture or trauma. Particular hypothermic regimens (e.g., temperature and rate of cooling) can be employed to treat particular conditions e.g. stroke vs. myocardial infarction so as to reduce the amount of ischemic reperfusion injury to vital organs resulting from the particular ischemic event.
Also, some embodiments can have hypothermic regimens for various surgical procedures to reduce the amount of post-surgical inflammation and to provide a tissue protective effect so as to extend the operating times for procedures that require reduced perfusion at the surgical site or throughout the body. Examples of the latter application include open-heart procedures where the heart can be cooled to allow for longer periods during which the heart is arrested and neurosurgical procedures to provide a neuro-protective effect for tissue at or near the operative site.
Selection of a particular hypothermic regimen can be made by the user from a database of regimens stored in memory resources within a system control unit (e.g., a console) or otherwise electronically coupled to the system either directly or wirelessly. In particular embodiments, the hypothermic regimen can be stored in a flash memory or other non-volatile memory device coupled to a disposable catheter set or kit used by the system. The memory device could then interface and upload the regimen to the control device, for example a docking station that the flash memory device plugs in to RF and other wireless interfaces to the system control device using BLUE TOOTH or another protocol are also contemplated.
These and related embodiments can also be utilized for patient resuscitation from various ischemic, hemorrhagic events (e.g., stroke or cardiac arrest) as well as shock through the use of peritoneal therapeutic solutions to oxygenate ischemic tissue, reduce reperfusion injury, and increase blood pressure by exerting a compressive force against the peritoneal or other body cavity vasculature. Such therapeutic solutions can include various peritoneal dialysis solutions which can comprise nutrients and one or more reperfusion injury protective agents. Also, the solution can comprise oxygenated solutions such as oxygenated fluorocarbon solutions that can be configured to deliver sufficient oxygen to tissue (by gas exchange with peritoneal or other surrounding tissue) to at least partially meet the oxygen demands of the body. For embodiments of the invention used to treat shock, the solution need not be chilled and can actually be warmed.
Also, many embodiments of the invention can be configured as a portable body cavity infusion/hypothermic system that can be readily transported in an ambulance, carried and used at a trauma scene by EMT's, military medics and emergency room personnel. Thus, one or more components of the system can include a handle, or the entire system can be integrated into an assembly having a handle. Further, as described herein, embodiments of a portable system can be configured for ease of use so as to require minimal set up time and manual dexterity by medical personnel. For example, embodiments of the system can use a subcutaneous access device that uses a stop or other means to control the depth of penetration into subcutaneous tissue so that the user need not have to precisely position the access device. This access device can be used in conjunction with an infusion catheter having a sensor configured to alert the user when the catheter has entered the peritoneal cavity so as to minimize or eliminate the risk of injuring a peritoneal organ. The infusion catheter can make use of quick connections for rapid connection to liquid and gas sources, fluid collection devices and other system components. The subsequent infusion and thermal control of fluids can then be automated through use of a computer controller or other electronic controller. In use, such embodiments provide a system with a fast set up time, high degree of reproducibility, and requires minimal dexterity and training of medical personnel.
One aspect of the invention provides a method of providing hypothermia to a patient. The method includes the steps of inserting a fluid delivery member into a peritoneal cavity of the patient; delivering hypothermia fluid from a fluid source into the peritoneal cavity through the delivery member; and limiting fluid pressure within the peritoneal cavity without providing feedback control to the fluid source. In some embodiments, the limiting step includes the step of extracting fluid from the peritoneal cavity when the pressure reaches a predetermined pressure, such as, e.g., by opening a pressure relief valve at the predetermined pressure.
In embodiments in which the fluid source includes a pump, the limiting step can include the step of limiting pump outlet pressure such as, e.g., by limiting torque on a moving pump component. In embodiments in which the fluid source includes a fluid container, the step of limiting fluid pressure can include the step of limiting height of the container over the patient.
In some embodiments, the delivering step includes the step of commencing delivery of fluid through the delivery member automatically when an outlet port of the delivery member enters the peritoneal cavity. The method may also include the step of activating a heat exchange element within the peritoneal cavity and/or cooling the fluid in the cavity, such as by using an endothermic reaction or using a compressed gas. In some embodiments, the method includes the step of cycling a fixed volume of fluid into and out of the peritoneal cavity.
In some embodiments, the fluid includes a hypertonic ice slurry and a hypotonic cold fluid. The hypertonic ice slurry and a hypotonic cold fluid together may be isotonic.
The fluid delivery member may be inserted into the peritoneal or other cavity in different ways in different embodiments. For example, in some embodiments the inserting step includes the step of inserting the fluid delivery member transgastrically or transrectally.
In some embodiments, the method includes the step of measuring patient temperature in e.g., the patient's trachea, esophagus and/or bladder. The measured temperature may be used to control fluid flow and/or temperature.
In some embodiments, the method includes the step of providing automated circulation to the patient with a CPR machine. Some embodiments also include the step of contacting an exterior surface of the patient with a cooling blanket.
Another aspect of the invention provides a hypothermia system including: a fluid source; a fluid delivery member adapted to be inserted into a peritoneal cavity of a patient; and a cavity pressure limiter adapted to limit fluid pressure within the peritoneal cavity without providing feedback control to the fluid source. Some embodiments also include a fluid extraction member adapted to extract fluid from the peritoneal cavity. In some such embodiments, the cavity pressure limiter has a pressure relief valve controlling flow of fluid through the fluid extraction member. The fluid extraction member may also have a weight at an inlet port.
In some embodiments, the fluid source includes a pump and the cavity pressure limiter includes a torque limiter (such as a clutch plate) in the pump. The fluid delivery member may also include a multi-lumen trocar.
Some embodiments of the invention include a heat exchange element supported by the fluid delivery member. The fluid source may include a hypertonic ice slurry and a hypotonic cold fluid, combinations of which may be isotonic.
Embodiments of the invention may also include delivery tools for the fluid delivery member, such as a transgastric delivery tool or a transrectal delivery tool. Some embodiments may also include a patient temperature sensor mounted on an endotracheal cuff, an esophageal catheter and/or a bladder catheter.
Some embodiments may also have a CPR machine adapted to provided automated circulation to the patient and/or a cooling blanket.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Embodiments of the invention provide apparatus, systems and methods for providing therapeutic hypothermia through minimally invasive access to the peritoneal cavity. Many embodiments provide a system for providing hypothermia, resuscitation or other treatment in response to stroke, myocardial infarction, blood loss or any condition resulting in decreased perfusion to one or more locations in the body, including both internal organs and the extremities. Embodiments of the invention may also be used with cadavers to preserve organs for later transplant. The term “patient” may be used herein to denote either living subjects requiring hypothermia therapy or dead subjects whose organs need to be preserved for transplant.
Also, the delivered fluid can contain one or more medicaments for treatment of myocardial infarction, cardiac arrest or other severe cardiac condition, stroke, shock, reperfusion injury or other medical conditions. Specific families of medicaments can include vasoconstrictors, hemolytic compounds (e.g., TPA, streptokinase and like compounds), anticoagulants, coagulants, calcium channel blockers, antibiotics, manitols. Also in specific embodiments, the delivered fluid can be configured to have resuscitative effects for treatment of heart attack, stroke, or severe blood loss. It can also have various agents known in the art for treatment of reperfusion injury. The delivered amount of a particular medicament can be titrated to the patient's weight and condition. Also, the dose of particular compounds can both be delivered as bolus with the initial bolus of hypothermic solution and also on a continuous basis. The delivery rate of a particular medicament or group of medicaments can also be controlled responsive to the patient's temperature, blood pressure, heart rate or other vital sign monitored manually, by system 10, or by other monitoring means.
The delivered fluid can also comprise oxygenated solutions such as supersaturated saline, oxygenated fluorocarbon solutions that can be configured to deliver sufficient oxygen to tissue (by gas exchange with peritoneal or other surrounding tissue) to at least partially meet the oxygen demands of the body. Fluorocarbon solutions can be pre-oxygenated or can be oxygenated in the fluid source 20 or outside of it using oxygen gas sources described herein. The delivered fluid can also include contrast media to allow for imaging by x-ray, MRI, ultrasound, and other imaging modalities known in the art.
A phase change solution, such as a slurry of ice, may be used within the cavity. Additives to the infusate may also be used to increase the cooling capacity of the fluid. One such additive is propylene glycol, but any safe compound may be used so long as it leads to greater cooling capacity. In some embodiments, a hypertonic ice slurry solution may be delivered to the patient's cavity followed by a hypotonic cold fluid with a net result of an isotonic fluid.
In various embodiments, such as some of those discussed below, the fluid source can include a patient cavity pressure limiter adapted to limit fluid pressure within the peritoneal or other cavity to which fluid delivery member 16 delivers fluid without providing feedback information or control to the fluid source. For example, in embodiments in which the fluid source is a bag of fluid suspended higher than the patient, the cavity pressure limiter could include a bag support (not shown) that limits the height of the bag over the patient cavity to which the fluid is being delivered. In embodiments in which the fluid source includes a pump, the cavity pressure limiter could include a controller controlling pump output pressure or a torque limiter (such as a clutch) limiting the output torque of a moving pump element. A high-flow, low-pressure pump may also be operated such that its output cannot exceed a predetermined pressure, such as, e.g., 10 cm H2O.
When used to treat a patient, the fluid delivery member 16 is inserted into the patient's peritoneal cavity 12 or other cavity. A trocar or other suitable instrument may be used to aid insertion and sealing of the insertion site. In some embodiments, an insertion sensor such as described in U.S. patent application Ser. No. 12/098,355 may also be used. After insertion, hypothermia fluid is delivered from the fluid source 20 to the patient's cavity 12 through the delivery member. Fluid pressure within the cavity is limited without providing pressure feedback information or control to the fluid source.
In another embodiment, the system may be used to infuse an initial bolus of fluid, or liquid/particulate mixture, but then may function as heat-exchanger to simply cool the fluid within the peritoneal cavity with no further fluid infusion and/or extraction required. For example, as shown in
In yet another embodiment, the fluid within the cavity may be cooled by an endothermic reaction which cools the peritoneal cavity via a chemical reaction. This reaction may be tailored to be temperature dependent and may be suspended or drastically slowed at the target temperature (typically within the 30-34 degree Celsius range). This reaction may also be generated within the fluid-filled cavity by a steady or intermittent infusion of reactive compounds which function to complete the endothermic reaction and lower the cavity temperature. Any endothermic chemical reaction may be used so long as it is biocompatible.
In yet another embodiment, instead of requiring the bag of fluid to be prechilled, it may be rapidly cooled using a CO2 cartridge or other source of compressed gas or endothermic reaction to cool fluid immediately prior to its infusion into the cavity. In another version of this embodiment, the fluid may be cooled as it enters into the cavity and may be kept at room temperature outside of the body. This relieves the requirement for prechilling and decreases the overall nursing burden.
In yet another embodiment of the invention, a fixed volume of fluid may be used that is safe for all patients (i.e., 1-2 L) and is then automatically cycled to achieve the desired cooling/warming rates, based, e.g., on the temperature of the fluid in the cavity and additional temperature sensors elsewhere in the body. In this embodiment, the volume of fluid in the cavity can be kept track of by the pump and fluid infusion/extraction may be coupled to ensure that excessive pressures are not generated and excessive volumes are not infused. Alternatively, a fixed volume of fluid may be infused and the pressure measured post-infusion. This post-infusion pressure may be maintained throughout the treatment cycle to ensure that a minimum volume of fluid is maintained within the cavity.
In the embodiment shown in
In the embodiment shown in
In many of the embodiments described above, the fluid delivery member accesses the patient's peritoneal cavity via an incision in the abdominal wall. Other means of accessing the peritoneal cavity are within the scope of the invention. For example, in the embodiment shown in
In some embodiments it may be desirable to monitor the patient's temperature. For example, exhaled air may be used as an indication of core temperature. As shown in
In some embodiments, the hypothermia system 90 may be combined with a CPR resuscitation system 92, as shown in
Additionally, the peritoneal infusion of cold or warm fluid could be used as an adjunct to other temperature management technologies. For example, 2 liters of cold fluid could be infused into the peritoneal cavity via a hypothermia system 100 in order to jump start the cooling process after which external cooling blankets 102 or other hypothermia producing therapies can be implemented, as shown in
In yet further embodiments, the IV fluid may be cooled with an ultrasonic refrigeration method. Or the tissues may be cooled directly via ultrasonic or other energy transmission means. One such example involves the use of an ultra-sonic cooling incorporated into a helmet for a neuro-protective device. These focused cooling technologies may be used to target any organ, though, including the heart, brain, liver, kidneys, etc. or may be used to cool the entire body.
Tissue penetration and placement of the fluid delivery member can be achieved in any manner known in the art, such as that described in US 2007/0106247, which has been incorporated herein by reference. The device may then report entry to the user and/or automatically initiate therapy.
To provide lumens for fluid infusion and for fluid extraction, a dual lumen catheter may be used.
This application claims priority under 35 U.S.C. §119 to U.S. Patent Application No. 60/958,717, filed Jul. 9, 2007, the disclosure of which is incorporated by reference as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
2078786 | Wood | Apr 1937 | A |
3042042 | Blanck | Jul 1962 | A |
3505988 | Deane | Apr 1970 | A |
3698396 | Katerndahl et al. | Oct 1972 | A |
3927980 | Leonard | Dec 1975 | A |
4302972 | Oettle et al. | Dec 1981 | A |
4356826 | Kubota | Nov 1982 | A |
4413633 | Yanda | Nov 1983 | A |
4424806 | Newman et al. | Jan 1984 | A |
4445500 | Osterholm | May 1984 | A |
4450841 | Osterholm | May 1984 | A |
4497324 | Sullivan et al. | Feb 1985 | A |
4535773 | Yoon | Aug 1985 | A |
4808157 | Coombs | Feb 1989 | A |
4813429 | Eshel et al. | Mar 1989 | A |
4883459 | Calderon | Nov 1989 | A |
4904237 | Janese | Feb 1990 | A |
4919134 | Streeter | Apr 1990 | A |
4963130 | Osterholm | Oct 1990 | A |
5108364 | Takezawa et al. | Apr 1992 | A |
5122267 | Giovanetti et al. | Jun 1992 | A |
5141492 | Dadson et al. | Aug 1992 | A |
5141493 | Jacobsen et al. | Aug 1992 | A |
5149321 | Klatz et al. | Sep 1992 | A |
5245367 | Miller et al. | Sep 1993 | A |
5249585 | Turner et al. | Oct 1993 | A |
5261891 | Brinkerhoff et al. | Nov 1993 | A |
5344136 | Capdeboscq | Sep 1994 | A |
5354277 | Guzman et al. | Oct 1994 | A |
5380160 | Chen | Jan 1995 | A |
5478329 | Ternamian | Dec 1995 | A |
5554280 | Loehr | Sep 1996 | A |
5562821 | Gutierrez-Collazo | Oct 1996 | A |
5623940 | Daikuzono | Apr 1997 | A |
5665227 | Watt | Sep 1997 | A |
5693017 | Spears et al. | Dec 1997 | A |
5709654 | Klatz et al. | Jan 1998 | A |
5709661 | Van Egmond et al. | Jan 1998 | A |
5730720 | Sites et al. | Mar 1998 | A |
5752929 | Klatz et al. | May 1998 | A |
5755756 | Freedman et al. | May 1998 | A |
5837003 | Ginsburg | Nov 1998 | A |
5916153 | Rhea, Jr. | Jun 1999 | A |
6019729 | Itoigawa et al. | Feb 2000 | A |
6019783 | Philips et al. | Feb 2000 | A |
6066163 | John | May 2000 | A |
6117076 | Cassidy | Sep 2000 | A |
6126684 | Gobin et al. | Oct 2000 | A |
6146411 | Noda et al. | Nov 2000 | A |
6149624 | McShane | Nov 2000 | A |
6149670 | Worthen et al. | Nov 2000 | A |
6165207 | Balding et al. | Dec 2000 | A |
6175688 | Cassidy et al. | Jan 2001 | B1 |
6188930 | Carson | Feb 2001 | B1 |
6197045 | Carson | Mar 2001 | B1 |
6231594 | Dae | May 2001 | B1 |
6254567 | Treu et al. | Jul 2001 | B1 |
6261312 | Dobak, III et al. | Jul 2001 | B1 |
6264680 | Ash | Jul 2001 | B1 |
6287326 | Pecor | Sep 2001 | B1 |
6290717 | Philips | Sep 2001 | B1 |
6299599 | Pham et al. | Oct 2001 | B1 |
6304776 | Muntermann | Oct 2001 | B1 |
6312452 | Dobak, III et al. | Nov 2001 | B1 |
6336910 | Ohta et al. | Jan 2002 | B1 |
6338727 | Noda et al. | Jan 2002 | B1 |
6368304 | Aliberto et al. | Apr 2002 | B1 |
6375674 | Carson | Apr 2002 | B1 |
6379331 | Barbut et al. | Apr 2002 | B2 |
6405080 | Lasersohn et al. | Jun 2002 | B1 |
6409699 | Ash | Jun 2002 | B1 |
6419643 | Shimada et al. | Jul 2002 | B1 |
6436295 | Kim | Aug 2002 | B2 |
6447474 | Balding | Sep 2002 | B1 |
6450990 | Walker et al. | Sep 2002 | B1 |
6451045 | Walker et al. | Sep 2002 | B1 |
6458150 | Evans et al. | Oct 2002 | B1 |
6460544 | Worthen | Oct 2002 | B1 |
6461379 | Carson et al. | Oct 2002 | B1 |
6480257 | Cassidy et al. | Nov 2002 | B2 |
6497721 | Ginsburg et al. | Dec 2002 | B2 |
6520933 | Evans et al. | Feb 2003 | B1 |
6529775 | Whitebook et al. | Mar 2003 | B2 |
6530945 | Noda et al. | Mar 2003 | B1 |
6530946 | Noda et al. | Mar 2003 | B1 |
6547811 | Becker et al. | Apr 2003 | B1 |
6551302 | Rosinko et al. | Apr 2003 | B1 |
6554797 | Worthen | Apr 2003 | B1 |
6572640 | Balding et al. | Jun 2003 | B1 |
6579496 | Fausset et al. | Jun 2003 | B1 |
6581403 | Whitebook et al. | Jun 2003 | B2 |
6582398 | Worthen et al. | Jun 2003 | B1 |
6585692 | Worthen | Jul 2003 | B1 |
6592577 | Abboud et al. | Jul 2003 | B2 |
6592612 | Samson et al. | Jul 2003 | B1 |
6602243 | Noda | Aug 2003 | B2 |
6620187 | Carson et al. | Sep 2003 | B2 |
6620189 | Machold et al. | Sep 2003 | B1 |
6635053 | Lalonde et al. | Oct 2003 | B1 |
6641602 | Balding | Nov 2003 | B2 |
6641603 | Walker et al. | Nov 2003 | B2 |
6645232 | Carson | Nov 2003 | B2 |
6645234 | Evans et al. | Nov 2003 | B2 |
6648905 | Hoglund et al. | Nov 2003 | B2 |
6660027 | Gruszecki et al. | Dec 2003 | B2 |
6669715 | Hoglund et al. | Dec 2003 | B2 |
6673098 | Machold et al. | Jan 2004 | B1 |
6676409 | Grant | Jan 2004 | B2 |
6676689 | Dobak, III et al. | Jan 2004 | B2 |
6682551 | Worthen et al. | Jan 2004 | B1 |
6685733 | Dae et al. | Feb 2004 | B1 |
6692518 | Carson | Feb 2004 | B2 |
6692519 | Hayes, Jr. | Feb 2004 | B1 |
6695873 | Dobak, III et al. | Feb 2004 | B2 |
6695874 | Machold et al. | Feb 2004 | B2 |
6699267 | Voorhees et al. | Mar 2004 | B2 |
6699268 | Kordis et al. | Mar 2004 | B2 |
6702842 | Dobak, III et al. | Mar 2004 | B2 |
6704590 | Haldeman | Mar 2004 | B2 |
6706060 | Tzeng et al. | Mar 2004 | B2 |
6709448 | Walker et al. | Mar 2004 | B2 |
6716236 | Tzeng et al. | Apr 2004 | B1 |
6719724 | Walker et al. | Apr 2004 | B1 |
6733517 | Collins | May 2004 | B1 |
6740109 | Dobak, III | May 2004 | B2 |
6743218 | Maginot et al. | Jun 2004 | B2 |
6746474 | Saadat | Jun 2004 | B2 |
6749625 | Pompa et al. | Jun 2004 | B2 |
6752786 | Callister | Jun 2004 | B2 |
6764391 | Grant et al. | Jul 2004 | B1 |
6796995 | Pham et al. | Sep 2004 | B2 |
6799063 | Carson | Sep 2004 | B2 |
6800068 | Dae et al. | Oct 2004 | B1 |
6802855 | Ellingboe et al. | Oct 2004 | B2 |
6807444 | Tu et al. | Oct 2004 | B2 |
6811551 | Dae et al. | Nov 2004 | B2 |
6818012 | Ellingboe | Nov 2004 | B2 |
6819950 | Mills | Nov 2004 | B2 |
6827728 | Ellingboe et al. | Dec 2004 | B2 |
6827898 | Fausset et al. | Dec 2004 | B1 |
6872222 | Luo et al. | Mar 2005 | B2 |
6878156 | Noda | Apr 2005 | B1 |
6887262 | Dobak, III et al. | May 2005 | B2 |
6887263 | Bleam et al. | May 2005 | B2 |
6893454 | Collins | May 2005 | B2 |
6921198 | Gruszecki et al. | Jul 2005 | B2 |
6974463 | Magers et al. | Dec 2005 | B2 |
6981945 | Sarvazyal et al. | Jan 2006 | B1 |
7001418 | Noda | Feb 2006 | B2 |
7008444 | Dae et al. | Mar 2006 | B2 |
7018399 | Dobak, III et al. | Mar 2006 | B2 |
7063718 | Dobak, III | Jun 2006 | B2 |
7070612 | Collins et al. | Jul 2006 | B1 |
7077825 | Stull | Jul 2006 | B1 |
7090792 | Balding et al. | Aug 2006 | B1 |
7097657 | Noda et al. | Aug 2006 | B2 |
7144407 | Lasersohn | Dec 2006 | B1 |
7172586 | Dae et al. | Feb 2007 | B1 |
7181927 | Collins et al. | Feb 2007 | B2 |
7255709 | Walker et al. | Aug 2007 | B2 |
7264680 | Gebhart et al. | Sep 2007 | B2 |
7276046 | Suzuki et al. | Oct 2007 | B1 |
7278984 | Noda et al. | Oct 2007 | B2 |
7287398 | Noda et al. | Oct 2007 | B2 |
7294142 | Dobak, III et al. | Nov 2007 | B2 |
7300453 | Yon | Nov 2007 | B2 |
7311724 | Ginsburg | Dec 2007 | B1 |
7311725 | Dobak, III | Dec 2007 | B2 |
7361186 | Voorhees et al. | Apr 2008 | B2 |
7371254 | Dobak, III | May 2008 | B2 |
7407487 | Dae et al. | Aug 2008 | B2 |
7425216 | Collins | Sep 2008 | B2 |
7458984 | Yon et al. | Dec 2008 | B2 |
7491223 | Lasheras | Feb 2009 | B2 |
7566341 | Keller et al. | Jul 2009 | B2 |
7640768 | Noda et al. | Jan 2010 | B2 |
7666213 | Freedman, Jr. et al. | Feb 2010 | B2 |
7666215 | Callister et al. | Feb 2010 | B2 |
7713241 | Cartledge et al. | May 2010 | B2 |
7771460 | Ginsburg et al. | Aug 2010 | B2 |
7819835 | Landy et al. | Oct 2010 | B2 |
7824436 | Barbut et al. | Nov 2010 | B2 |
7827005 | Kimball | Nov 2010 | B2 |
20010035046 | Williams | Nov 2001 | A1 |
20020026094 | Roth | Feb 2002 | A1 |
20020033181 | Groth et al. | Mar 2002 | A1 |
20020147481 | Brugger et al. | Oct 2002 | A1 |
20030018279 | Rosenblatt | Jan 2003 | A1 |
20030131844 | Kumar et al. | Jul 2003 | A1 |
20030135087 | Hickle et al. | Jul 2003 | A1 |
20040087606 | Voorhees et al. | May 2004 | A1 |
20040102826 | Lasheras et al. | May 2004 | A1 |
20040122353 | Shahmirian et al. | Jun 2004 | A1 |
20040138701 | Haluck | Jul 2004 | A1 |
20040158119 | Osorio et al. | Aug 2004 | A1 |
20040172116 | Seifert et al. | Sep 2004 | A1 |
20040193098 | Wentling et al. | Sep 2004 | A1 |
20040231664 | Lurie et al. | Nov 2004 | A1 |
20050033391 | Worthen et al. | Feb 2005 | A1 |
20050172212 | Birsa et al. | Aug 2005 | A1 |
20050177212 | Njemanze | Aug 2005 | A1 |
20050203598 | Becker et al. | Sep 2005 | A1 |
20060025839 | Gonzales | Feb 2006 | A1 |
20060064146 | Collins | Mar 2006 | A1 |
20060161107 | Mantle | Jul 2006 | A1 |
20060190066 | Worthen | Aug 2006 | A1 |
20060276864 | Collins | Dec 2006 | A1 |
20060293734 | Scott et al. | Dec 2006 | A1 |
20070027393 | Williams et al. | Feb 2007 | A1 |
20070045188 | Blanton | Mar 2007 | A1 |
20070051409 | Landy, III et al. | Mar 2007 | A1 |
20070106247 | Burnett et al. | May 2007 | A1 |
20070173755 | Alimi et al. | Jul 2007 | A1 |
20070203552 | Machold et al. | Aug 2007 | A1 |
20070225781 | Saadat et al. | Sep 2007 | A1 |
20080045867 | Jensen et al. | Feb 2008 | A1 |
20080077088 | Collins | Mar 2008 | A1 |
20080077206 | Collins | Mar 2008 | A1 |
20080119757 | Winter | May 2008 | A1 |
20080119788 | Winter | May 2008 | A1 |
20080154197 | Derrico et al. | Jun 2008 | A1 |
20080200863 | Chomas et al. | Aug 2008 | A1 |
20080234619 | Fausset et al. | Sep 2008 | A1 |
20080255644 | Carson | Oct 2008 | A1 |
20090099629 | Carson et al. | Apr 2009 | A1 |
20090124937 | Parks | May 2009 | A1 |
20090131835 | Voorhees et al. | May 2009 | A1 |
20090240312 | Koewler | Sep 2009 | A1 |
20090312676 | Rousso et al. | Dec 2009 | A1 |
20100305656 | Imran et al. | Dec 2010 | A1 |
Number | Date | Country |
---|---|---|
2135552 | Dec 2009 | EP |
2267829 | Dec 1993 | GB |
H05-038327 | Feb 1993 | JP |
07-275358 | Oct 1995 | JP |
H08-508176 | Sep 1996 | JP |
09-108340 | Apr 1997 | JP |
2001-029459 | Feb 2001 | JP |
2001-87392 | Apr 2001 | JP |
3387602 | Mar 2003 | JP |
2003533243 | Nov 2003 | JP |
2004-329763 | Nov 2004 | JP |
2004538087 | Dec 2004 | JP |
2005211652 | Aug 2005 | JP |
2005-528160 | Sep 2005 | JP |
2005527331 | Sep 2005 | JP |
2005536277 | Dec 2005 | JP |
100378358 | May 2003 | KR |
WO 9313718 | Jul 1993 | WO |
WO 9804191 | Feb 1998 | WO |
WO 9965552 | Dec 1999 | WO |
WO 0048670 | Aug 2000 | WO |
WO 0072779 | Dec 2000 | WO |
WO 0103606 | Jan 2001 | WO |
WO 0117471 | Mar 2001 | WO |
WO 0139819 | Jun 2001 | WO |
WO 0141708 | Jun 2001 | WO |
WO 0158509 | Aug 2001 | WO |
WO 0226175 | Apr 2002 | WO |
WO 0226176 | Apr 2002 | WO |
WO 0226285 | Apr 2002 | WO |
WO 0226307 | Apr 2002 | WO |
WO 02058606 | Aug 2002 | WO |
WO 03005908 | Jan 2003 | WO |
WO 03059218 | Jul 2003 | WO |
WO 2006060514 | Jun 2006 | WO |
WO 2009071094 | Jun 2009 | WO |
WO 2009071096 | Jun 2009 | WO |
WO 2009071097 | Jun 2009 | WO |
WO 2009071098 | Jun 2009 | WO |
WO 2009071095 | Jun 2009 | WO |
Entry |
---|
Sedlak, S. Kay; Hypothermia in trauma: the nurse's role in recognition, prevention, and management; Int'l Journal of Trauma Nursing; ; vol. 1; No. 1; pp. 19-26; Jan. 1995. |
Mantle, Ross E.; U.S. Appl. No. 12/916,076 entitled “Device for the extravascular recirculation of fluid in body cavities,” filed Oct. 29, 2010. |
Burnett et al.; U.S. Appl. No. 12/615,045 entitled “Devices and Methods for Monitoring Core Temperature and an Intraperitoneal Parameter,” filed Nov. 9, 2009. |
Hall et al.; U.S. Appl. No. 12/702,165 entitled “Method and Apparatus for Inducing Therapeutic Hypothermia,” filed Feb. 8, 2010. |
Polderman et al.; Effects of therapeutic hypothermia on intracranial pressure and outcome in patients with severe head injury; Intensive Care Med; vol. 28; pp. 1563-1573; 2002. |
Demling et al.; Initial management of burn patient; (from Burnsurgery.org); 2004. |
Rutherford et al.; Management of the patient with an open abdomen: techniques in temporary and definitive closure; Curr Probl Surg; vol. 41; pp. 821-876; 2004. |
Sieh et al.; Intra-abdominal hypertension and abdominal compartment syndrome; Langenbeck's Arch Surg; vol. 386; pp. 53-61; 2001. |
Hwang et al.; Peri-operative concerns in thoracic trauma; Bailliére's Clinical Anaesthesiology; vol. 10; No. 1; pp. 123-153; 1996. |
Stover et al.; Treating intracranial hypertension in patients with severe traumatic brain injury during neurointensive care; European Journal of Trauma; 2005(4); pp. 308-330; 2005. |
Burnett et al.; U.S. Appl. No. 12/098,355 entitled “Device and method for safe access to a body cavity,” filed Apr. 4, 2008. |
Burnett et al.; U.S. Appl. No. 12/098,365 entitled “Automated therapy system and method,” filed Apr. 4, 2008. |
Davison et al.; Epidural cooling for regional spinal cord hypothermia during thoracoabdominal aneurysm repair; J. Vasc. Surg.; vol. 20(2); No. 304-10; Aug. 1994 (Abstract Only). |
Hall et al.; U.S. Appl. No. 13/275,189 entitled “Method and Apparatus for Inducing Therapeutic Hypothermia,” filed Oct. 17, 2011. |
Burnett et al.; U.S. Appl. No. 13/354,210 entitled “Automated Therapy System and Method,” filed Jan. 19, 2012. |
Number | Date | Country | |
---|---|---|---|
20090076573 A1 | Mar 2009 | US |
Number | Date | Country | |
---|---|---|---|
60958717 | Jul 2007 | US |